Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Oncology Reports

Issue 6/2021

Content (13 Articles)

Acupuncture Integrative Care (C Lammersfeld, Section Editor)

Integrative Approaches to Minimize Peri-operative Symptoms

Fahad Faruqi, Kathryn J. Ruddy, Shanda Blackmon

Human Papillomavirus Gynecologic Cancers (J Brown and RW Naumann, Section Editors)

Immunotherapy in Cervical Cancer

Dennis Mauricio, Burak Zeybek, Joan Tymon-Rosario, Justin Harold, Alessandro D. Santin

osteosarcoma Orthopedic Oncology (JA Abraham, Section Editor)

Update on Osteosarcoma

Rebekah Belayneh, Mitchell S. Fourman, Sumail Bhogal, Kurt R. Weiss

Lung Cancer Interventional Oncology (DC Madoff, Section Editor)

Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy

Yuan-Mao Lin, Ryosuke Taiji, Marco Calandri, Bruno C. Odisio

Artificial Intelligence Interventional Oncology (DC Madoff, Section Editor)

Role of Machine Learning and Artificial Intelligence in Interventional Oncology

Brian D’Amore, Sara Smolinski-Zhao, Dania Daye, Raul N. Uppot

Brachytherapy Interventional Oncology (DC Madoff, Section Editor)

Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy

Florentine E.F. Timmer, Bart Geboers, Sanne Nieuwenhuizen, Evelien A.C. Schouten, Madelon Dijkstra, Jan J.J. de Vries, M. Petrousjka van den Tol, Tanja D. de Gruijl, Hester J. Scheffer, Martijn R. Meijerink

Acupuncture Breast Cancer (AS Zimmer, Section Editor)

Managing Common Estrogen Deprivation Side Effects in HR+ Breast Cancer: an Evidence-Based Review

Bethânia Soares dos Santos, Cláudia Bordignon, Daniela Dornelles Rosa

Chronic Lymphocytic Leukemia Leukemia (A Aguayo, Section Editor)

Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia

Maria Montserrat Aguilar-Hernandez, Julio César Rincon Camacho, Gabriela Galicia Garcia

Myelodysplastic Syndrome Leukemia (A Aguayo, Section Editor)

Erythroleukemia: an Update

Olga K. Weinberg, Daniel A. Arber

Cardio-oncology (EH Yang, Section Editor)

Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building

Diego Sadler, Anita Arnold, Joerg Herrmann, Andres Daniele, Carolina Maria Pinto Domingues Carvalho Silva, Arjun K Ghosh, Sebastian Szmit, Roohi Ismail Khan, Luis Raez, Anne Blaes, Sherry-Ann Brown

Care Palliative Medicine (A Jatoi, Section Editor)

Organizational Strategies for Providing Cancer Palliative Care to Many

Arunangshu Ghoshal, Anuja Damani, Jayita Deodhar, Mary Ann Muckaden

Open Access Carcinoid Tumor Neuroendocrine Neoplasms (NS Reed, Section Editor)

Update on Histological Reporting Changes in Neuroendocrine Neoplasms

Konstantin Bräutigam, Antonio Rodriguez-Calero, Corina Kim-Fuchs, Attila Kollár, Roman Trepp, Ilaria Marinoni, Aurel Perren

Correction

Correction to: Psychosocial Interventions for Pain Management in Advanced Cancer Patients: a Systematic Review and Meta-analysis

Marco Warth, Joshua Zöller, Friederike Köhler, Corina Aguilar-Raab, Jens Kessler, Beate Ditzen

May 21
Issue: 5/2021
Jul 21
Issue: 7/2021

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits